Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Authors:
- A Fry-SmithAFA Fry-Smith
Open Access
- 1 April 2008
- journal article
- research article
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 12 (11) , 1-278, iii
Abstract
Health Technology Assessment Volume: 12, Issue: 11, Published in April 2008Keywords
Funding Information
- Health Technology Assessment Programme (03/34/01)
This publication has 213 references indexed in Scilit:
- COX-2 Inhibitors, Other NSAIDs, and Cardiovascular RiskJAMA, 2006
- Use of Aspirin and Ibuprofen Compared With Aspirin Alone and the Risk of Myocardial InfarctionArchives of internal medicine (1960), 2004
- Ulcer Prevention in Long-term Users of Nonsteroidal Anti-inflammatory DrugsArchives of internal medicine (1960), 2002
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- Rofecoxib, a New Cyclooxygenase 2 Inhibitor, Shows Sustained Efficacy, Comparable With Other Nonsteroidal Anti-inflammatory Drugs: A 6-Week and a 1-Year Trial in Patients With OsteoarthritisArchives of Family Medicine, 2000
- Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in OsteoarthritisArchives of internal medicine (1960), 2000
- A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients With OsteoarthritisArchives of internal medicine (1960), 2000
- Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDsJAMA, 1999
- A Study of Manufacturer-Supported Trials of Nonsteroidal Anti-inflammatory Drugs in the Treatment of ArthritisArchives of internal medicine (1960), 1994
- Concurrent Use of Nonsteroidal Anti-inflammatory Drugs and Oral Anticoagulants Places Elderly Persons at High Risk for Hemorrhagic Peptic Ulcer DiseaseArchives of internal medicine (1960), 1993